课题基金 / 基金详情

CD44 MEDIATED FIBROBLAST MIGRATION IN A WOUND MODEL

CD44 MEDIATED FIBROBLAST MIGRATION IN A WOUND MODEL
CD44 介导的伤口模型中的成纤维细胞迁移
批准号:
2708584
负责人:
STEVEN J MONTANTE
金额:
$3.15万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
未结题
起止时间:
1999-01-16 至

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective of this project is to examine the mechanisms by which the CD44 cell surface receptor mediates human dermal fibroblast migration into the provisional fibrin matrix. Wound healing is a finely organized cascade of events involving the interactions of a variety of cell types, growth factors, and extracellular matrix proteins. In addition to providing hemostasis and protection, the fibrin plug which forms immediately upon wounding serves as a lattice on which fibroblasts migrate to begin the healing process. Studies of human alveolar fibroblasts derived from patients with acute lung injury implicate the CD44 cell surface receptor in invasion of the provisional matrix. CD44 is a family of cell surface receptors implicated in lymphocyte homing as well as tumor cell migration and metastasis. The integrin cell surface receptors have been implicated in human dermal fibroblast invasion of the provisional wound matrix; however, the role of CD44 in the mechanism of dermal fibroblast migration is unknown. This proposal will test the hypothesis that CD44 is a mediator of human dermal fibroblast migration into the provisional wound matrix. The study will examine: 1. CD44-mediated dermal fibroblast adhesion to various provisional matrix components; 2. CD44-mediated dermal fibroblast migration along provisional matrix components; and 3. CD44-mediated dermal fibroblast invasion of a fibrin gel. Understanding the mechanisms of fibroblast migration will provide a basis for the development of novel therapies in the treatment of fibrotic disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位: